Production (Stage)
Serina Therapeutics, Inc.
SER
$6.00
$0.254.35%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.52M | -16.72M | -12.93M | -12.59M | -11.40M |
| Total Depreciation and Amortization | 186.00K | 194.00K | 144.00K | 142.00K | 102.00K |
| Total Amortization of Deferred Charges | 323.00K | 345.00K | 337.00K | 329.00K | 22.00K |
| Total Other Non-Cash Items | -10.32M | 2.52M | 3.58M | 6.18M | 7.60M |
| Change in Net Operating Assets | -3.56M | -3.48M | -3.56M | -4.55M | 338.00K |
| Cash from Operations | -19.88M | -17.14M | -12.43M | -10.49M | -3.34M |
| Capital Expenditure | -8.00K | -22.00K | -87.00K | -203.00K | -518.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -8.00K | -22.00K | -87.00K | -203.00K | -518.00K |
| Total Debt Issued | 643.00K | 3.04M | 2.93M | 2.93M | 2.40M |
| Total Debt Repaid | -155.00K | -168.00K | -180.00K | -184.00K | -50.00K |
| Issuance of Common Stock | 10.00M | 10.00M | 5.08M | 5.01M | 19.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.92M | 337.00K | 337.00K | 337.00K | 337.00K |
| Cash from Financing | 15.40M | 13.21M | 8.17M | 8.08M | 2.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.49M | -3.95M | -4.35M | -2.61M | -1.16M |